[CUE] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
03-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 16.53%
YoY- -1.16%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,336 2,100 68 2,395 704 984 449 39.64%
PBT -8,660 -11,005 -10,955 -12,992 -10,031 -6,990 -12,559 -6.00%
Tax 0 700 -76 2 -123 -99 -102 -
NP -8,660 -11,005 -10,879 -12,993 -10,031 -6,990 -12,559 -6.00%
Tax Rate - - - - - - - -
Total Cost 11,996 13,105 10,947 15,388 10,735 7,974 13,008 -1.33%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -259.59 -524.05 -15,998.53 -542.51 -1,424.86 -710.37 -2,797.10 -32.68%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.17 -0.24 -0.31 -0.41 -0.34 -0.31 -0.62 -19.38%
EPS Diluted -0.17 -0.24 -0.31 -0.41 -0.34 -0.31 -0.62 -19.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.